Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 322
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03587558 | Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract | ||
| NCT03802162 | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 | ||
| NCT06112678 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6) | ||
| NCT05749861 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5) | ||
| NCT05634447 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391 | ||
| NCT05335044 | Study to Evaluate the Safety and Pharmacokinetics of CKD-331 | ||
| NCT06492655 | To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers | ||
| NCT03210649 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT04431687 | A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393) | ||
| NCT01340248 | A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers | ||
| NCT06916793 | A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia | ||
| NCT05193565 | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients | ||
| NCT04623021 | A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | ||
| NCT05897216 | Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029 | ||
| NCT01756430 | Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension | ||
| NCT01842230 | Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine | ||
| NCT04555434 | Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH | ||
| NCT04388215 | Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet | ||
| NCT03414840 | Assessment of Change in Atherosclerotic Plaque by Serial CCTA | ||
| NCT01356043 | CKD-828 Drug Interaction Study (S-amlodipine) | ||
| NCT02777723 | Study to Evaluate the Efficacy and Safety of CKD-350 | ||
| NCT04667975 | The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy | ||
| NCT04869800 | Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg | ||
| NCT02753504 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT04651881 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions | ||
| NCT03713892 | CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects | ||
| NCT05526742 | A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects | ||
| NCT02894541 | Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT04521023 | A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy | ||
| NCT04987970 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg | ||
| NCT05526703 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy | ||
| NCT03671941 | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers | ||
| NCT03431623 | CKD-11101 Phase 3 SC Study | ||
| NCT02645890 | Study to Compare the Safety and Pharmacokinetics of CKD-397 | ||
| NCT04272502 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers | ||
| NCT01030679 | Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus | ||
| NCT03569579 | CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1) | ||
| NCT04867720 | Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients | ||
| NCT05347576 | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions | ||
| NCT02484482 | Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI) | ||
| NCT04611932 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers | ||
| NCT02480465 | Efficacy and Safety of Lobeglitazone Versus Sitagliptin | ||
| NCT05834595 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 | ||
| NCT05043467 | Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus | ||
| NCT03062059 | The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence | ||
| NCT04830930 | A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers | ||
| NCT05566028 | The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes | ||
| NCT02498509 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 | ||
| NCT03794492 | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome | ||
| NCT03641352 | The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes |
